Trial Profile
Retrospective evaluation of retigabine in patients with cognitive impairment with highly drug-resistant epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Retigabine (Primary)
- Indications Epilepsy; Partial epilepsies
- Focus Therapeutic Use
- 01 Dec 2015 New trial record